We were thrilled to talk with Lynn Lewis, founder and CEO of Gilmartin Group, who gave us her thoughts on negotiating the many hurdles a company needs to clear before concluding a successful IPO on Nasdaq. After spending half her career as a Wall Street equity research analyst and investor evaluating companies in life sciences […]
2025 has already begun with drama in the U.S., as Los Angeles recovers from deadly wildfires and Donald Trump is sworn in for his second presidency. And so it was that the mood going into the annual JP Morgan Healthcare Conference was clouded by uncertainty. With its timing in January, JPM is often seen as […]
Optimum’s clients fight off the January blues as JP Morgan conference sets positive tone for ‘25 INTRO: Our amazing clients had the perfect tonic for the cold January weather with a string of announcements, including $41 million of funding for Bioptimus and the publication of cutting-edge research into mitophagy in Nature Reviews Drug Discovery. We’re […]
Christmas is but a distant memory and spring is definitely not around the next corner. So, you probably don’t need reminding that it’s “Blue Monday” next week (January 20th) – supposedly the most depressing day of the year. For most of us, Blue Monday at least gives us an excuse to feel rotten; we drag […]
Poolbeg Pharma plc and HOOKIPA Pharma Inc. kicked off 2025 in a positive fashion, entering into non-binding discussions for an all-share acquisition by HOOKIPA of Poolbeg The aim is to create a strong clinical-stage biopharmaceutical company focused on developing and commercialising innovative medicines for critical unmet medical needs, with a special focus on next-generation immunotherapies […]
